Document Detail

Clinical application of amplicon-based next-generation sequencing in cancer.
MedLine Citation:
PMID:  24332266     Owner:  NLM     Status:  Publisher    
Next-generation sequencing (NGS) technology has revolutionized genomic research by decreasing the cost of sequencing while increasing the throughput. The focus now is on potential clinical applications of NGS technology for diagnostics and therapeutics. Clinical applications of NGS in cancer can detect clinically actionable genetic/genomic alterations that are critical for cancer care. These alterations can be of diagnostic, prognostic, or therapeutic significance. In certain cancers, patient risk and prognosis can be predicted based on the mutation profile identified by NGS. Many targeted therapies have been developed for cancer patients who bear specific mutations; however, choosing the right NGS technique for the appropriate clinical application can be challenging, especially in clinical oncology, where the material for NGS tests is often limited and the turnaround time (TAT) for cancer tests is constrained to a few days. Currently, amplicon-based NGS approaches have emerged as the best fit for clinical oncology. In this review, we focus on amplicon-based library preparation, sequencing, sequence data alignment and annotation, and post-analytic interpretation and reporting.
Fengqi Chang; Marilyn M Li
Related Documents :
20300916 - Seeking to bridge two cultures: the wisconsin hmong cancer experience.
20148936 - Patient preferences for the delivery of bad news - the experience of a uk cancer centre.
24373486 - Optimizing ventana chromogenic dual in-situ hybridization for mucinous epithelial ovari...
24689646 - Dna hypomethylation in plasma as a cancer biomarker: when less is more?
9927346 - Long-term inhalable particles and other air pollutants related to mortality in nonsmokers.
17280876 - Heteroplasmic mutation of mitochondrial dna d-loop and 4977-bp deletion in human cancer...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-10-11
Journal Detail:
Title:  Cancer genetics     Volume:  -     ISSN:  2210-7762     ISO Abbreviation:  Cancer Genet     Publication Date:  2013 Oct 
Date Detail:
Created Date:  2013-12-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101539150     Medline TA:  Cancer Genet     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunot...
Next Document:  The effect of hydration on mechanical anisotropy, topography and fibril organization of the osteonal...